Serum total renin levels after ovarian electrocautery in women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 12, Issue 5, 1998, Pages 327-331

  Anttila, L ^a   Penttila T A ^a   Matinlauri, I ^a   Koskinen, P ^a   Irjala, K ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Ovarian electrocautery; Polycystic ovary syndrome; Total renin

Indexed keywords

ANGIOTENSIN; LUTEINIZING HORMONE; PRORENIN; RENIN;

ADULT; ARTICLE; CAUTERIZATION; CLINICAL ARTICLE; FEMALE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; OLIGOMENORRHEA; OVARY; OVARY POLYCYSTIC DISEASE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031773577     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599809012834     Document Type: Article

References (25)

1. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dys-regulation of androgen secretion. Endocr Rev 1995; 16:322-53
2. Armar NA, Lachelin GCL. Laparoscopic ovarian diathermy: an effective treatment for anti-oestrogen resistant anovulatory infertility in women with the polycystic ovary syndrome. Br J Obstet Gynaecol 1993;100:161-4
3. Naether OGJ, Fischer R, Weise HC, et al. Laparoscopic electrocoagulation of the ovarian surface in infertile patients with polycystic ovarian disease. Fertil Steril 1993;60:88-94
4. Gjönnaess H. Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results. Acta Obstet Gynecol Scand 1994;73:407-12
5. Abdel Gadir A, Mowafi RS, Alnaser HMI, et al. Ovarian electrocautery versus human menopausal gonadotropins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin Endocrinol 1990;33: 585-92
6. Abdel Gadir A, Alnaser HMI, Mowafi RS, et al. The response of patients with polycystic ovarian disease to human menopausal gonadotropin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist. Fertil Steril 1992;57:309-13
7. Rimington MR, Walker SM, Shaw RW. The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries. Hum Reprod 1997;12:1443-7
8. Armar NA, McGarrigle HHG, Honour J, et al. Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome. Fertil Steril 1990;53:45-9
9. Donesky BW, Adashi EY. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril 1995;63:439-63
10. Farhi J, Soule S, Jacobs HS. Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 1995;64:930-5
11. Matinlauri I, Anttila L, Jaatinen T-A, et al. Total renin after gonadotropin stimulation in polycystic ovarian disease. Fertil Steril 1995;63:307-13
12. Jaatinen T-A, Matinlauri I, Anttila L, et al. Serum total renin is elevated in women with polycystic ovarian syndrome. Fertil Steril 1995;63:1000-4
13. Matinlauri I, Eskola JU, Aalto M, et al. Time-resolved immunofluorometric assay of total renin in plasma and follicular fluid. Clin Chem 1994;40: 74-9
14. Morris RS, Paulson RJ. Ovarian derived prorenin-angiotensin cascade in human reproduction. Fertil Steril 1994;62:1105-14
15. Vinson GP, Saridogan E, Puddefoot JR, et al. Tissue renin-angiotensin systems and reproduction. Hum Reprod 1997;12:651-62
16. Derkx FHM, Schalekamp MADH. Human prorenin: pathophysiology and clinical implication. Clin Exp Hypertens 1998;A1:1213-25
17. Do YS, Sherrod A, Lobo RA, et al. Human ovarian theca cells are a source of renin. Proc Natl Acad Sci USA 1998;85:1957-61
18. Sealey JE, Cholst I, Clorioso N, et al. Sequential changes in plasma luteinizing hormone and plasma prorenin during menstrual cycle. J Clin Endocrinol Metab 1987;63:1-5
19. Blankestijn PJ, Derkx FHM, van Geelen JA, et al. Increase in plasma prorenin during the menstrual cycle of bilaterally nephrectomized women. Br J Obstet Gynaecol 1990;97:1038-42
20. Johnson MC, Vega M, Vantman D, et al. Regulatory role of angiotensin II on progesterone production by cultured human granulosa cells. Expression of angiotensin II type-2 receptor. Mol Hum Reprod 1997;3:663-8
21. Morris RS, Wong IL, Hatch IE, et al. Prorenin is elevated in polycystic ovary syndrome and may reflect hyperandrogenism. Fertil Steril 1995;64: 1099-103
22. Glorioso N, Sealey JE, Quimby FW, et al. Ovarian secretion of prorenin in response to exogenous and endogenous gonadotropin stimulation. Presented at 11th Scientific Meeting of the International Society of Hypertension, (Abstract) 1986
23. Palumbo A, Pourmotabbed G, Carcangiu ML, et al. Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertil Steril 1993; 60:280-4
24. Dewailly D, Robert Y, Helm I, et al. Ovarian stromal hypertrophy in hyperandrogenic women. Clin Endocrinol 1994;41:557-62
25. Gilling-Smith C, Willis DS, Beard RW, et al. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 1994;79:1158-65